Replies to post #363075 on Amarin Corp Plc (AMRN)

[ralphey]

100% premium - that would be $6.60 for AMRN ...lol

[ziploc_1]

"Pfizer has the ability to do $132 billion in deals through 2022. “We see this as the first of many deals for Pfizer,”

Pfizer might also want to look at Vascepa as a first treatment for use in UC, Crohn's and IBS.

Anti-inflammatory Vascepa is a safe alternative treatment for inflammatory bowel diseases...It can be used alone or as a relatively inexpensive add on to the more dangerous anti-immune drugs and steroids.